BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6100066)

  • 21. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
    Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
    Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
    Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella vaccine studies in healthy children and adults.
    Arbeter AM; Starr SE; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children's ward.
    Ozaki T; Nagayoshi S; Morishima T; Isomura S; Suzuki S; Asano Y; Takahashi M
    Biken J; 1978 Jun; 21(2):69-72. PubMed ID: 219841
    [No Abstract]   [Full Text] [Related]  

  • 31. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Active chickenpox vaccination of children with acute leukemia or other neoplastic diseases].
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Klin Padiatr; 1985; 197(6):477-80. PubMed ID: 3003449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
    Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live varicella vaccine in severely immunodepressed children.
    Ninane J; Latinne D; Heremans-Bracke MT; De Bruyere M; Cornu G
    Postgrad Med J; 1985; 61 Suppl 4():97-102. PubMed ID: 3014486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 39. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.